Preview

Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)

Advanced search
Open Access Open Access  Restricted Access Subscription or Fee Access

On the issue of the etiology of community-acquired pneumonia in children

https://doi.org/10.21508/1027-4065-2024-69-5-13-21

Abstract

According to global statistics, the number of cases of community-acquired pneumonia in children exceeds 150 million per year, and despite the introduction of vaccinations, this figure has not significantly decreased. Respiratory viruses, particularly respiratory syncytial virus, are recognized as the main cause of community-acquired pneumonia among preschool children during non-epidemic periods. Pneumococci also continue to play a significant role among bacterial pathogens. There is a significant increase in the prevalence of M. pneumoniae in the etiological structure of community-acquired pneumonia in recent years. Modern clinical guidelines for the use of antibiotics recommend taking into account patient age, vaccination status, and data on circulating pneumococcal strains when prescribing treatment. The COVID-19 pandemic and its subsequent relaxation of strict restrictions in the last two years have led to changes in the structure of infectious diseases, including the causes of lower respiratory tract infections.

About the Authors

S. V. Khaliullina
Kazan State Medical Academy
Russian Federation

Kazan



V. A. Anokhin
Kazan State Medical Academy
Russian Federation

Kazan



M. R. Gataullin
Republican Clinical Infectious Diseases Hospital
Russian Federation

Kazan



T. Yu. Pavlova
Republican Clinical Infectious Diseases Hospital
Russian Federation

Kazan



R. I. Valiev
Kazan State Medical Academy
Russian Federation

Kazan



References

1. Chuchalin A.G., Geppe N.A., Rozinova N.N. Modern classification of clinical forms of bronchopulmonary diseases in children. Pediatriya. Zhurnal im. G.N. Speranskogo 2010; 4: 6–15. (in Russ.)

2. Tkacheva A.A., Polyakova A.S., Bakradze M.D., Tatochenko V.K., Yasakov D.S. Community-acquired pneumonia in children. Farmateka 2021; 1: 68–71. (in Russ.)

3. Rodrigues C.M.C., Groves H. Community-Acquired Pneumonia in Children: the Challenges of Microbiological Diagnosis. J Clin Microbiol 56: 10.1128/jcm.01318–17

4. DOI: 10.1128/jcm.01318–17

5. Harris M., Clark J., Coote N., Fletcher P., Harnden A., McKean M. et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011; 66: ii1–ii23. DOI: 10.1136/thoraxjnl-2011–200598

6. Pneumonia in children. WHO. (in Russ.) https://www.who.int/ru/news-room/fact-sheets/detail/pneumonia / Ссылка активна на 11.06.2024.

7. Liu L., Oza S., Hogan D., Chu Y., Perin J., Zhu J. et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 2016; 388(10063): 3027–3035. DOI: 10.1016/S0140–6736(16)31593–8

8. Lee J., Zhu Yu., Williams D.J., Self W.H., Arnold S.R., McCullers J.A. et al. Red blood cell distribution width and pediatric community-acquired pneumonia disease severity. Hospital Pediatrics 2022; 12(9): 798–805. DOI: 10.1542/hpeds.2022–006539

9. Bradley J.S., Byington C.L., Shah S.S., Alverson B., Carter E.R., Harrison C. et al. Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53(7): e25–76. DOI: 10.1093/cid/cir531

10. Yadav K.K., Awasthi S. Childhood Pneumonia: What’s Unchanged, and What’s New? Indian J Pediatr 2023; 90(7): 693–699. DOI: 10.1007/s12098–023–04628–3

11. McAllister D.A., Liu L., Shi T., Chu Y., Reed C., Burrows J. et al. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health 2019; 7(1): e47–e57. DOI: 10.1016/S2214–109X(18)30408-X

12. Jain S., Williams D.J., Arnold S.R., Ampofo K., Bramley A.M., Reed C. et al. CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015; 372(9): 835–45. DOI: 10.1056/NEJMoa1405870

13. Pneumonia. UNICEF https://data.unicef.org/topic/childhealth/pneumonia / Ссылка активна на 11.06.2024.

14. Mardian Y., Menur Naysilla A., Lokida D., Farida H., Aman A.T., Karyana M. et al. Approach to Identifying Causative Pathogens of Community-Acquired Pneumonia in Children Using Culture, Molecular, and Serology Tests. Front Pediatr 2021; 9: 629318. DOI: 10.3389/fped.2021.629318

15. Farnaes L., Wilke J., Ryan Loker K., Bradley J.S., Cannavino C.R., Hong D.K. et al. Community-acquired pneumonia in children: cell-free plasma sequencing for diagnosis and management. Diagn Microbiol Infect Dis 2019; 94(2): 188–191. DOI: 10.1016/j.diagmicrobio.2018.12.016

16. Johansson N., Kalin M., Tiveljung-Lindell A., Giske C.G., Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010; 50(2): 202–209. DOI: 10.1086/648678

17. Gordon O., Oster Y., Michael-Gayego A., Marans R.S., Averbuch D., Engelhard D. et al. The Clinical Presentation of Pediatric Mycoplasma pneumoniae Infections-A Single Center Cohort. Pediatr Infect Dis J 2019; 38(7): 698–705. DOI: 10.1097/INF.0000000000002291

18. Bradley J.S., Byington C.L., Shah S.S., Alverson B., Carter E.R., Harrison C. et al. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53(7): e25–e76. DOI: 10.1093/cid/cir531

19. Meyer Sauteur P.M. Childhood community-acquired pneumonia. Eur J Pediatr 2024; 183: 1129–1136. DOI: 10.1007/s00431–023–05366–6

20. Elemraid M.A., Sails A.D., Eltringham G.J.A., Perry J.D., Rushton S.P., Spencer D.A. et al. Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine. Eur Respir J 2013; 42: 1595–1603. DOI: 10.1183/09031936.00199112

21. Wallihan R.G., Suárez N.M., Cohen D.M., Marcon M., Moore-Clingenpeel M., Mejias A. et al. Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia. Front Cell Infect Microbiol 2018; 8: 382. DOI: 10.3389/fcimb.2018.00382

22. Protasova I.N., Peryanova O.V., Ilyenkova N.A. Etiological diagnosis of community-acquired pneumonia in children. Pul’monologiya 2014; 5: 78–82. (in Russ.) DOI: 10.18093/0869–0189–2014–0–5–78–82

23. Bradley J.S., Byington C.L., Shah S.S. Alverson B., Carter E.R., Harrison C. et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53: e25–76. DOI: 10.1093/cid/cir531

24. Borovkova M.G., Krasnov M.V., Nikolaeva L.A., Grigorieva M.N., Akimova V.P. Clinical course of community-acquired pneumonia in hospitalized children. Sovremennye problemy nauki i obrazovaniya 2021; 6. (in Russ.). https://science-education.ru/ru/article/view?id=31343 / Ссылка активна на 11.06.2024.

25. Geppe N.A., Malakhov A.B., Dronov I.A., Khabibullina E.A. Community-acquired pneumonia in children: problems of diagnosis, treatment and prevention. Doktor. ru 2015; 114(13): 20–27. (in Russ.)

26. Yun K.W., Wallihan R., Desai A., Alter S., Ambroggio L., Cohen D.M. et al. Children’s Hospitals Initiative for Research in Pneumonia. Clinical Characteristics and Etiology of Community-acquired Pneumonia in US Children, 2015–2018. Pediatr Infect Dis J 2022; 41(5): 381–387. DOI: 10.1097/INF.0000000000003475

27. Wrotek A., Robakiewicz J., Pawlik K., Rudzinski P., Pilarska I., Jaroń A. et al. The Etiology of Community-Acquired Pneumonia Correlates with Serum Inflammatory Markers in Children. J Clin Med 2022; 11(19): 5506. DOI: 10.3390/jcm11195506

28. Bénet T., Sánchez Picot V., Messaoudi M., Chou M., Eap T., Wang J. et al. Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) Network; Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) Network. Microorganisms Associated With Pneumonia in Children <5 Years of Age in Developing and Emerging Countries: The GABRIEL Pneumonia Multicenter, Prospective, Case-Control Study. Clin Infect Dis 2017; 65(4): 604–612. DOI: 10.1093/cid/cix378

29. Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet 2019; 394(10200): 757–779. DOI: 10.1016/S0140–6736(19)30721–4

30. Lokida D., Farida H., Triasih R., Mardian Y., Kosasih H., Naysilla A.M. et al. Epidemiology of community-acquired pneumonia among hospitalised children in Indonesia: a multicentre, prospective study. BMJ Open 2022; 12(6): e057957. DOI: 10.1136/bmjopen-2021–057957

31. Rueda Z.V., Aguilar Y., Maya M.A., López L., Restrepo A., Garcés C. et al. Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents. BMC Pediatr 2022; 22(1): 169. DOI: 10.1186/s12887–022–03235-z

32. Gareca Perales J., Soleto Ortiz L., Loayza Mafayle R., Machuca Soto B., Hidalgo Flores L., López Montaño J. et al. Diagnosis of Community-acquired Pneumonia in Hospitalized Children: A Multicenter Experience in Bolivia. Pediatr Infect Dis J 2021; 40(1): 32–38. DOI: 10.1097/INF.0000000000002909

33. Lee C.H., Won Y.K., Roh E.J., Suh D.I., Chung E.H. A nationwide study of children and adolescents with pneumonia who visited Emergency Department in South Korea in 2012. Korean J Pediatr 2016; 59(3): 132–138. DOI: 10.3345/ kjp.2016.59.3.132

34. Suh J.H., Ahn B., Song S.H., Choi S., Choi S.H., Lee H. et al. Etiology and Clinical Characteristics of Community-Acquired Pneumonia in Korean Children During the Pre- COVID-19 Period, 2015–2020. J Korean Med Sci 2023; 38(43): e339. DOI: 10.3346/jkms.2023.38.e339

35. Zhang L.N., Cao, L., Meng L.H. Pathogenic changes of community-acquired pneumonia in a children’s hospital in Beijing, China before and after COVID-19 onset: a retrospective study. World J Pediatr 2022; 18: 746–752. DOI: 10.1007/s12519–022–00592–8

36. del Rosal T., Bote-Gascón P., Falces-Romero I., Sainz T., Baquero-Artigao F., Rodríguez-Molino P. et al. Multiplex PCR and Antibiotic Use in Children with Community-Acquired Pneumonia. Children 2024; 11(2): 245. DOI: 10.3390/children11020245

37. Tran X.D., Hoang V.T., Goumballa N., Vu T.N., Tran T.K., Pham T.D. et al. Viral and bacterial microorganisms in Vietnamese children with severe and non-severe pneumonia. Sci Rep 2024; 14(1): 120. DOI: 10.1038/s41598–023–50657–5

38. Chen D., Cao L., Li W. Etiological and clinical characteristics of severe pneumonia in pediatric intensive care unit (PICU). BMC Pediatr 2023; 23: 362. DOI: 10.1186/s12887–023–04175-y

39. Levina A.S., Babachenko I.V., Sharipova E.V., Ibragimova O.M., Kvetnaya A.S., Kalinogorskaya O.S. et al. Etiological characteristics of community-acquired pneumonia in children depending on age. Pul’monologiya 2014; 5: 62–66. (in Russ.) DOI: 10.18093/0869–0189–2014–0–5–62–66

40. Ploskireva A.A., Khlypovka Yu.N., Yatsyshina S.B., Nikolaeva S.V., Gorelov A.V. Etiology of community-acquired pneumonia in children. RMZH. Meditsinskoye obozreniye 2018; 8(II): 50–54. (in Russ.)

41. Bhuiyan M.U., Snelling T.L., West R., Lang J., Rahman T., Borland M. et al. Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case-control study protocol. BMJ Open 2018; 8(3): e020646. DOI: 10.1136/bmjopen-2017–020646

42. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002; 346(6): 429–437. DOI: 10.1056/NEJMra011994. PMID: 11832532

43. Koshy E., Murray J., Bottle A., Sharland M., Saxena S. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) program on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997–2008. Thorax 2010; 65(9): 770–774. DOI: 10.1136/thx.2010.137802

44. Rhedin S., Lindstrand A., Hjelmgren A., Ryd-Rinder M., Ohrmalm L., Tolfvenstam T. et al. Respiratory viruses associated with community-acquired pneumonia in children: matched case-control study. Thorax 2015; 70(9): 847–853. DOI: 10.1136/thoraxjnl-2015–206933

45. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006;19(3): 571–582. DOI: 10.1128/CMR.00058–05

46. Sender V., Hentrich K., Henriques-Normark B. Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae. Front Cell Infect Microbiol 2021; 11: 643326. DOI: 10.3389/fcimb.2021.643326

47. Simonsen L., Fukuda K., Schonberger L.B., Cox N.J. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181(3): 831–7. DOI: 10.1086/315320

48. Popovsky E.Y., Florin T.A. Community-Acquired Pneumonia in Childhood. Encyclopedia of Respiratory Medicine. 2022: 119–131. DOI: 10.1016/B978–0–08–102723–3.00013–5

49. Hooven T.A., Polin R.A. Pneumonia. Seminars in Fetal and Neonatal Medicine 2017; 22(4): 206–213. DOI: 10.1016/j.siny.2017.03.002

50. Pelton S.I., Hammerschlag M.R. Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children. Clinical Pediatrics 2005; 44(1): 1–17. DOI: 10.1177/000992280504400101

51. Sun Y.P., Zheng X.Y., Zhang H.X., Zhou X.M., Lin X.Z., Zheng Z.Z. et al. Epidemiology of Respiratory Pathogens Among Children Hospitalized for Pneumonia in Xiamen: A Retrospective Study. Infect Dis Ther 2021; 10: 1567–1578. DOI: 10.1007/s40121–021–00472–0

52. Shi T., McLean K., Campbell H., Nair H. Etiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta-analysis. J Glob Health 2015; 5(1): 010408. DOI: 10.7189/jogh.05.010408

53. Self W.H., Williams D.J., Zhu Y., Ampofo K., Pavia A.T., Chappell J.D. et al. Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. J Infect Dis 2016; 213(4): 584–91. DOI: 10.1093/infdis/jiv323

54. Maloletnikova I.M., Paramonova N.S. Etiological structure of acute community-acquired pneumonia in children. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta 2024; 22(1): 73–77. (in Russ.) DOI: 10.25298/2221–8785–2024–22–1–73–77

55. Danino D., Ben-Shimol S., van der Beek B.A., Givon-Lavi N., Avni Y.S., Greenberg D. et al. Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study. Clin Infect Dis 2022; 75(1): e1154–e1164. DOI: 10.1093/cid/ciab1014


Review

For citations:


Khaliullina S.V., Anokhin V.A., Gataullin M.R., Pavlova T.Yu., Valiev R.I. On the issue of the etiology of community-acquired pneumonia in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2024;69(5):13-21. (In Russ.) https://doi.org/10.21508/1027-4065-2024-69-5-13-21

Views: 296


ISSN 1027-4065 (Print)
ISSN 2500-2228 (Online)